Covalent complexes of proteasome model with peptide aldehyde inhibitors MG132 and MG101: docking and molecular dynamics study

Abstract20S proteasome plays a critical role in the regulation of several important cellular processes and has drawn extensive interest in the field of anti-tumor research. Peptide aldehydes can inhibit the 20S proteasome activity by covalently binding to the active site of the β subunits. In this work, covalent docking in conjunction with molecular dynamics (MD) simulation was used to explore the binding mode of MG132. Two conformations with the lowest docking energy were selected as the representative binding modes. One of the conformations was confirmed as a more reasonable binding mode by molecular dynamics simulations. The binding mode analysis revealed that a space demanding aromatic group with a short linker at the P4 site of the peptide aldehyde inhibitor would form favorable hydrophobic contacts with the neighboring subunit. A bulky substituent at the P2 position would also increase the binding stability by reducing water accessibility of the covalent bond. This study contributed to our understanding of the mechanism and structure-activity relationship of the peptide aldehyde inhibitors and may provide useful information for rational drug design.

[1]  A. Berger,et al.  On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.

[2]  A. Goldberg,et al.  The Sizes of Peptides Generated from Protein by Mammalian 26 and 20 S Proteasomes , 1999, The Journal of Biological Chemistry.

[3]  T. Mizushima,et al.  The structure of the mammalian 20S proteasome at 2.75 A resolution. , 2002, Structure.

[4]  M. Orłowski,et al.  Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex. , 1992, Biochemistry.

[5]  S Omura,et al.  The proteasome is involved in angiogenesis. , 1998, Biochemical and biophysical research communications.

[6]  R. Huber,et al.  Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. , 1995, Science.

[7]  R. Huber,et al.  Crystal structures of Salinosporamide A (NPI-0052) and B (NPI-0047) in complex with the 20S proteasome reveal important consequences of beta-lactone ring opening and a mechanism for irreversible binding. , 2006, Journal of the American Chemical Society.

[8]  Hisashi Ito,et al.  Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine. , 1996, Journal of biochemistry.

[9]  M. Groll,et al.  20S proteasome and its inhibitors: crystallographic knowledge for drug development. , 2007, Chemical reviews.

[10]  Yun Tang,et al.  3D-QSAR studies on fluoropyrrolidine amides as dipeptidyl peptidase IV inhibitors by CoMFA and CoMSIA , 2007, Journal of molecular modeling.

[11]  J. Palmer,et al.  Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and cellular properties of potent, selective proteasome inhibitors. , 2006, Journal of medicinal chemistry.

[12]  W. Risau,et al.  Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  Xiaomin Zou,et al.  Design and synthesis of a novel class of furan-based molecules as potential 20S proteasome inhibitors. , 2007, Bioorganic & medicinal chemistry letters.

[14]  Peter A. Kollman,et al.  AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules , 1995 .

[15]  W Keilholz,et al.  Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Q. Dou,et al.  Proteasome inhibitors as potential novel anticancer agents. , 1999, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[17]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[18]  Jianfeng Pei,et al.  3D-QSAR studies on tripeptide aldehyde inhibitors of proteasome using CoMFA and CoMSIA methods. , 2006, Bioorganic & medicinal chemistry.

[19]  L. Dick,et al.  Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids. , 1998, Bioorganic & medicinal chemistry letters.

[20]  M. Orłowski,et al.  A multicatalytic protease complex from pituitary that forms enkephalin and enkephalin containing peptides. , 1981, Biochemical and biophysical research communications.

[21]  Y. Umezawa,et al.  Structure-based design of derivatives of tyropeptin A as the potent and selective inhibitors of mammalian 20S proteasome. , 2005, Bioorganic & medicinal chemistry letters.

[22]  A. Goldberg,et al.  Selective Inhibitors of the Proteasome-dependent and Vacuolar Pathways of Protein Degradation in Saccharomyces cerevisiae * , 1996, The Journal of Biological Chemistry.

[23]  A. Hershko.  Lessons from the discovery ofthe ubiquitin system , 1996 .

[24]  Tom Maniatis,et al.  The ubiquitinproteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB , 1994, Cell.

[25]  W. Delano.  The PyMOL Molecular Graphics System (2002) , 2002 .

[26]  A. Goldberg,et al.  A soluble ATP-dependent proteolytic system responsible for the degradation of abnormal proteins in reticulocytes. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[27]  JB Almond,et al.  The proteasome: a novel target for cancer chemotherapy , 2002, Leukemia.

[28]  W. Guida,et al.  Docking studies and model development of tea polyphenol proteasome inhibitors: Applications to rational drug design , 2003, Proteins.

[29]  R. Huber,et al.  Structure of 20S proteasome from yeast at 2.4Å resolution , 1997, Nature.

[30]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[31]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[32]  A. Goldberg,et al.  Proteasome inhibitors: from research tools to drug candidates. , 2001, Chemistry & biology.

[33]  Dunming Zhu,et al.  A molecular modeling study on the enantioselectivity of aryl alkyl ketone reductions by a NADPH-dependent carbonyl reductase , 2007, Journal of molecular modeling.